Patient Comment Submission Form Bladder Cancer - Follow-Up Surveillance- MedicineNet.com

Bladder Cancer - Follow-Up Surveillance

What types of follow-up procedures or tests did you have to detect recurrences of bladder cancer?

Share your story with others:

MedicineNet appreciates your comment. Your comment may be displayed on the site and will always be published anonymously.Patient Comments FAQs

Enter your Comment

Tell us a bit about your background to make your comments more useful to other MedicineNet users. (Optional)

Screen Name: *

Gender of Patient: Male Female

Age Range of Patient:

I am a: Patient Caregiver


* Screen Name will appear next to the published comment. Please do not include your full name or email address.

By submitting your comment, and other materials (collectively referred to as a "Submission") to MedicineNet, you grant MedicineNet permission to use, copy, transmit, publish, display, edit and modify your Submission in connection with its Web site. MedicineNet will not pay you for your Submission. You represent that you have all rights necessary for MedicineNet to use your Submission as set forth above.

Please keep these guidelines in mind when writing your comment:

  • Please make sure you address the question asked.
  • Due to the overwhelming number of comments received, not all comments will be published.
  • When selecting comments to publish, our staff will choose those that are educational and complement the topic. Please try to stay on topic.
  • Your comment may be edited. We would typically edit comments to make them clearer and more readable. We will remove personal information such as last names, email and web addresses, and other potentially harmful information.
  • We will not notify you if your comment has been published. We suggest that you check back on the topic article regularly.
  • We do not provide medical or healthcare advice, treatment, or diagnosis.

Thank you for participating!


I have read and agree to abide by the MedicineNet Terms and Conditions and the MedicineNet Privacy Policy (required).

To prevent our systems from spam, please complete the following prior to submitting your comment.

Please select the white square:

What is surveillance for bladder cancer?

Patients diagnosed and treated with superficial bladder cancer need to be followed up regularly to detect recurrences and treat them effectively. The following is a typical follow-up protocol:

  • Cystoscopy and urine cytology every three months for two years, every six months for the next two to three years and annually thereafter


  • Imaging study (CT scan/intravenous urogram) of the kidneys and ureters once every year (especially for high-grade tumors/those associated with CIS)

Cystoscopy and cytology detects recurrence in the bladder itself while CT/IVU is used to detect a tumor in the kidneys and ureters. Patients with bladder cancer are more likely to get upper-tract tumors which arise from the inner lining of these organs and share a common origin with bladder tumors. The risk of upper-tract recurrence depends on the stage and grade of the initial disease and the response of the tumor to BCG. Individuals with recurrent high-grade bladder tumors can have up to a 20% risk of developing a tumor in the upper tracts and need to be followed closely in this regard.

Commercially available tumor markers which are used to test urine samples for evidence of bladder tumor recurrence are also being used in follow-up protocols. However, their exact role is undefined as of now and they are not considered an adequate substitute for cystoscopy and cytology. Some of these markers are NMP 22, BTA Stat, BTA Trak, and UroVysion.

Return to Bladder Cancer

Stay Informed!

Get the latest health and medical information delivered direct to your inbox FREE!